编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
122941 | Pacritinib(SB1518) | 937272-79-2 | ≧98.0% | ![]() |
Pacritinib (SB1518) 是一种高选择性激酶抑制剂,对 JAK2、FLT3、IRAK1 和 | ||||
1662118 | MK-8931 ( Verubecestat ) | 1286770-55-5 | 98% by HPLC/HNMR | ![]() |
MK-8931(verubecestat)是一种BACE抑制剂,是由默沙东公司研制开发。主 | ||||
611902 | PF-04979064 | 1220699-06-8 | ≧98.0% | ![]() |
PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50) | ||||
6111110 | Nastorazepide | 209219-38-5 | 98% | ![]() |
Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative | ||||
6112701 | JPH203(KYT-0353) | 1037592-40-7 | ≧98.0% | ![]() |
JPH203(also known as KYT-0353) is a potent and selective LAT1 selective ( L-type amin | ||||
6121401 | Vadadustat ( AKB-6548 ) | 1000025-07-9 | 98% | ![]() |
Vadadustat (AKB-6548), a novel, titratable, oral hypoxia-inducible factor prolyl hydr | ||||
16122810 | Elacestrant dihydrochloride | 1349723-93-8 | ≧98.0% | ![]() |
Elacestrant dihydrochloride, also known as RAD1901, is an orally available, selective | ||||
16122847 | WWL70 | 947669-91-2 | ≧98.0% | ![]() |
WWL70是选择性ABHD6抑制剂,在创伤性脑损伤和多发性硬化症的动物 | ||||
16123054 | MK-1064 | 1207253-08-4 | ≧98.0% | ![]() |
MK-1064是一种有效的、选择性和口服的Orexin OX2受体拮抗剂,用于治 | ||||
1710901 | Netarsudil (AR-13324) 2HCl | 1253952-02-1 | ≧98.0% | ![]() |
Netarsudil (a.k.a. AR-13324)是一种ROCK抑制剂,Ki值为 0.2-10.3 nM。它目前 | ||||
71161 | SBI0206965 | 1884220-36-3 | 98% | ![]() |
SBI0206965是一种有效的选择性自噬激酶ULK1抑制剂。许多肿瘤变得沉 | ||||
17012102 | lumateperone(Tosylate) | 1187020-80-9 | 98% | ![]() |
Lumateperone (ITI-722/ITI-007)是一种新型的双5HT2A受体拮抗剂/多巴胺磷蛋 |